Characterization of focal liver lesions with SonoVue- enhanced sonography: International multicenter-study in comparison to CT and MRI
AIM: To evaluate in a multicenter study whether the sonographic characterization of focal liver lesions can be improved using SonoVue-enhancement; and to compare this method with computed tomography (CT) and magnetic resonance imaging (MRI). METHODS: One hundred and thirty four patients withone foca...
Saved in:
Cover
Loading…
Summary: | AIM: To evaluate in a multicenter study whether the sonographic characterization of focal liver lesions can be improved using SonoVue-enhancement; and to compare this method with computed tomography (CT) and magnetic resonance imaging (MRI).
METHODS: One hundred and thirty four patients withone focal liver lesion detected in baseline ultrasound (US) were examined with conventional US, contrastenhanced US (n = 134), contrast-enhanced CT (n = 115) and/or dynamic contrast-enhanced MRI (n = 70). The lesions were classified as malignant, benign or indeterminate and the type of lesion was determined. The final diagnosis based on the combined information of all imaging examinations, clinical information and histology (n = 32) was used. Comparisons were made to see whether the addition of contrast-enhanced US led to the improvement of the characterization of doubtful focal liver lesions.
RESULTS: In comparison with unenhanced US, SonoVue markedly improves sensitivity and specificity for the characterization (malignant/benign) of focal liver lesions. In comparison with CT and/or dynamic MRI, SonoVue -enhanced sonography applied for characterization of focal liver lesions was 30.2% more sensitive in the recognition of malignancy and 16.1% more specific in the exclusion of malignancy and overall 22.9% more accurate. In the subgroup with confirmative histology available (n = 30), sensitivity was 95.5% (CEUS), 72.2% (CT) and 81.8% (MRI), and specificity was 75.0% (CEUS), 37.5% (CT) and 42.9% (MRI). The sensitivity and specificity of CEUS for the identification of focal nodular hyperplasia (FNH) and hemangiomas was 100% and 87%, resulting in an accuracy of 94.5%.
CONCLUSION: SonoVue-enhanced sonography emerges as the most sensitive, ost specific and thus most accurate imaging modality for the characterization of focal liver lesions. |
---|---|
Bibliography: | Sonography Contrast-enhanced sonography; Contrastmedia; Dynamic sonography; Liver lesion; Liverdisease; Liver; Oncologic imaging; Sonography Contrastmedia 14-1219/R Liver Contrast-enhanced sonography Liver lesion TP391.41 Oncologic imaging O174.14 Liverdisease Dynamic sonography ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Undefined-2 Author contributions: Bruel JM and Greis C designed the study; Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, Oyen R, Jakubowski W, Danes J contributed to the patient’s inclusion; Trillaud H and Greis C performed data analysis and interpretation and wrote the paper. Telephone: +33-5-56795800 Correspondence to: Hervé Trillaud, MD, PhD, Hospital Saint André and University Victor Segalen Bordeaux 2, 1 rue Jean Burguet, 33075 Bordeaux, France. herve.trillaud@chu-bordeaux.fr Fax: +33-5-56794764 |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.15.3748 |